Matsuoka Ken-ichi

マツオカケンイチ | Matsuoka Ken-ichi

Affiliation and department：

Research field (2)： Immunology , Hematology and oncology

Research keywords (3)：造血幹細胞移植 , 移植片対宿主病 , 制御性T細胞

Research theme for competitive and other funds (5)：

2020 - 2023 移植急性期のB細胞恒常性異常に基づく慢性GVHD発症予測と先制的治療法の開発
2017 - 2020 Development of a novel algorithm for immune regulation that enables the active Treg amplification soon after HSCT
2015 - 2018 Low-dose IL-2 therapy to maintain Treg homeostasis under the use of calcineurin inhibitor
2014 - 2017 Low-dose IL-2 combined with PD-1 blockade separates GVHD and GVL effect.
2012 - 2014 Restoration of Treg homeostasis with Low-dose IL-2 administiration for patients with refractory chronic GVHD

Papers (185)：

Masaharu Tamaki, Shunto Kawamura, Kosuke Takano, Hirohisa Nakamae, Noriko Doki, Hiroyuki Ohigashi, Yumiko Maruyama, Shuichi Ota, Nobuhiro Hiramoto, Tetsuya Eto, et al. Female-to-male allogeneic transplantation affects outcomes differently according to the type of haplo-transplantation. Cytotherapy. 2024
Toshiki Terao, Takumi Kondo, Makoto Nakamura, Hiroki Takasuka, Hideaki Fujiwara, Noboru Asada, Daisuke Ennishi, Hisakazu Nishimori, Keiko Fujii, Nobuharu Fujii, et al. Combination of reduced post-transplant cyclophosphamide and early tacrolimus initiation increases the incidence of chronic graft-versus-host disease in human leukocyte antigen-haploidentical peripheral blood stem-cell transplantation. EJHaem. 2024. 5. 4. 810-814
Akira Yamamoto, Hisakazu Nishimori, Keisuke Seike, Hideaki Fujiwara, Noboru Asada, Daisuke Ennishi, Keiko Fujii, Nobuharu Fujii, Ken-Ichi Matsuoka, Yoshinobu Maeda. Simulation-based Bone Marrow Aspiration and Trephine Biopsy Education for Medical Students: A Non-randomized Controlled Trial. Internal medicine (Tokyo, Japan). 2024
Kentaro Ido, Hirohisa Nakamae, Norimichi Hattori, Minoru Kanaya, Kaoru Morita, Masayuki Hino, Hiroyuki Ohigashi, Takahiro Fukuda, Tetsuya Eto, Koji Nagafuji, et al. Effect of peptide-binding motif on survival of HLA-haploidentical transplantation with post-transplant cyclophosphamide. British journal of haematology. 2024
Yumi Inukai Motokura, Hisao Higo, Chiaki Matsumoto, Mari Uno, Kanako Fujiwara, Toshiki Terao, Satoko Makimoto, Fumiyo Higaki, Ken-Ichi Matsuoka, Fumiaki Tokioka, et al. Remission of hypersensitivity pneumonitis after allogeneic hematopoietic stem cell transplantation. Respiratory investigation. 2024. 62. 5. 759-761

ｍore...

MISC (89)：

寺尾俊紀, 松岡賢市. Maintenance therapy of FLT3 inhibitors post-allogenic stem cell transplantation. 月刊血液内科. 2023. 87. 1
松原千哲, 松岡賢市, 近藤歌穂, 藤原加奈子, 寺尾俊紀, 植田裕子, 松村彰文, 守山喬史, 村上裕之, 近藤匠, et al. 臍帯血移植後にHTLV-1感染T細胞の多クローン性増殖を伴って発症した肺合併症に対しCCR4抗体が著効した一例. 日本血液学会学術集会抄録(Web). 2023. 85th
横出晃能, 藤原雅樹, 酒本真次, 佐藤涼太, 三島桃子, 矢田勇慈, 寺尾俊紀, 植田裕子, 近藤匠, 松岡賢市, et al. クロザピン誘発性無顆粒球症経過中に侵襲性肺アスペルギルス症を発症した一例. 総合病院精神医学. 2022. 34. Supplement
小沼貴晶, 糸永英弘, 石山謙, 土岐典子, 内田直之, 小澤幸泰, 片山雄太, 片岡圭亮, 上田恭典, 松岡賢市, et al. Trends of allogeneic transplant outcomes for adult myelodysplastic syndrome in Japan. 日本造血・免疫細胞療法学会総会プログラム・抄録集. 2022. 45th
小西達矢, 松田健佑, 糸永英弘, 土岐典子, 小澤幸泰, 松岡賢市, 池田宇次, 神田善伸, 福田隆浩, 諫田淳也, et al. Impact of early CMV reactivation on relapse in adult patients with MDS after allogeneic HSCT. 日本造血・免疫細胞療法学会総会プログラム・抄録集. 2022. 45th

ｍore...

Books (4)：

白血病治療マニュアル改訂第4版
2022
血液疾患最新の治療 2023-2025
2022
EBM血液疾患の治療 2019-2020
2019
GVHD(移植片対宿主病)の基礎と臨床
2012

Education (2)：

2002 - 2006 Okayama University Graduate School of Medicine , Dentistry and Pharmaceutical Sciences
1992 - 1999 Okayama University Medical School Faculty of Medicine

Professional career (1)：

医学博士 (岡山大学大学院)

Work history (9)：

2021/04 - 現在岡山大学学術研究院医歯薬学域血液・腫瘍・呼吸器内科学分野准教授
2018/01 - 2021/03 Okayama University Graduate School of Medicine , Dentistry and Pharmaceutical Sciences
2016/04 - 2017/12 岡山大学病院血液・腫瘍内科講師
2011/04 - 2016/03 岡山大学病院血液・腫瘍内科助教
2006/11 - 2011/03 ハーバード大学ダナファーバーがん研究所血液腫瘍部門

Show all

Committee career (15)：

2022/10 - 現在日本血液学会年次総会プログラム委員
2022/06 - 現在日本造血・免疫細胞療法学会年次総会プログラム委員
2022/04 - 現在日本造血・免疫細胞療法学会移植施設認定委員
2021/10 - 現在日本HTLV-1学会評議員
2021/10 - 現在日本血液学会試験問題作成委員

Show all

Awards (1)：

2013/10 - Incentive award The Impact of Recent Thymic Emigrant Regulatory T cells (RTE-Treg) on the Tolerance after HSCT

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page